GlaxoSmithKline
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- ZANTAC effervescent tablet 150 mg
- ZANTAC film-coated tablet 150 mg
- ZANTAC film-coated tablet 300 mg
- ZANTAC solution for injection 50 mg/2 ml
- A10 - Antidiabéticos
- AVANDAMET film-coated tablet 1 000 mg+2 mg
- AVANDAMET film-coated tablet 1 000 mg+4 mg
- AVANDAMET film-coated tablet 500 mg+1 mg
- AVANDAMET film-coated tablet 500 mg+2 mg
- AVANDIA film-coated tablet 4 mg
- AVANDIA film-coated tablet 8 mg
- B01 - Agentes antitrombóticos
- ARIXTRA solution for injection 2.5 mg/0.5 ml
- FRAXIPARINA solution for injection 2 850 IU anti-Xa/0.3 ml
- FRAXIPARINA solution for injection 3 800 IU Anti-Xa/0.4 ml
- FRAXIPARINA solution for injection 5 700 IU Anti-Xa/0.6 ml
- FRAXIPARINA solution for injection 7 600 IU Anti-Xa/0.8 ml
- FRAXODI solution for injection 11 400 IU Anti-Xa/0.6 ml
- FRAXODI solution for injection 15 200 IU Anti-Xa/0.8 ml
- INTEGRILIN solution for infusion 75 mg/100 ml
- INTEGRILIN solution for injection 20 mg/10 ml
- B02 - Antihemorrágicos
- REVOLADE film-coated tablet 25 mg
- REVOLADE film-coated tablet 50 mg
- C02 - Antihipertensivos
- VOLIBRIS film-coated tablet 5 mg
- G04 - Urológicos
- DUAGEN capsule, soft 0.5 mg
- JUTEO capsule, soft 0.4 mg+0.5 mg
- J01 - Antibacterianos para uso sistémico
- AUGMENTIN DUO film-coated tablet 875 mg+125 mg
- AUGMENTIN DUO powder for oral suspension 400 mg/5 ml+57 mg/5 ml
- AUGMENTIN ES powder for oral suspension 600 mg/5 ml+42.9 mg/5 ml
- AUGMENTIN film-coated tablet 500 mg+125 mg
- AUGMENTIN FORTE powder for oral suspension 250 mg/5 ml+62.5 mg/5 ml
- AUGMENTIN powder for oral suspension 125 mg/5 ml+31.25 mg/5 ml
- SPECTRACEF film-coated tablet 200 mg
- SPECTRACEF film-coated tablet 400 mg
- J07 - Vacunas
- CERVARIX suspension for injection
- SYNFLORIX suspension for injection
- L01 - Antineoplásicos
- ARZERRA concentrate for solution for infusion 100 mg/5 ml
- ATRIANCE solution for infusion 250 mg/50 ml
- TYVERB film-coated tablet 250 mg
- VOTRIENT film-coated tablet 200 mg
- VOTRIENT film-coated tablet 400 mg
- L04 - Inmunosupresores
- BENLYSTA powder for solution for infusion 120 mg
- BENLYSTA powder for solution for infusion 400 mg
- N01 - Anestésicos
- ULTIVA powder for solution for infusion 1 mg
- ULTIVA powder for solution for infusion 2 mg
- ULTIVA powder for solution for infusion 5 mg
- N06 - Psicoanalépticos
- SEROXAT film-coated tablet 20 mg
- SEROXAT oral suspension 2 mg/ml
- WELLBUTRIN prolonged-release tablet 300 mg
- WELLBUTRIN XR prolonged-release tablet 150 mg
- P01 - Antiprotozoarios
- MALARONE film-coated tablet 100 mg+250 mg
- R01 - Preparaciones nasales
- AVAMYS nasal spray, suspension 27.5 µg/dose